Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 29 2024 - 4:30PM
Business Wire
Incyte (Nasdaq:INCY) announced today that it granted equity
inducement awards to Matteo Trotta, the Company’s new Executive
Vice President and General Manager of U.S. Dermatology, pursuant to
the Company’s 2024 Inducement Stock Incentive Plan. The awards were
approved by the compensation committee of the Company’s Board of
Directors as an inducement material to the new employee entering
into employment with the Company in accordance with Nasdaq Listing
Rule 5635(c)(4).
Mr. Trotta received an award of 7,828 restricted stock units
(RSUs) and an award of stock options to purchase 21,868 shares of
the Company’s common stock, in each case with a grant and vesting
commencement date of March 25, 2024.
The RSUs vest as to 25% of the shares subject to the RSUs on
each of the first four anniversaries of the vesting commencement
date, subject to the employee's continued service with the Company
on each such date. The stock options have an exercise price of
$57.48 per share, which is equal to the closing price of the
Company’s common stock on the grant date. The stock option award
has a ten year term and vests as to 25% of the original number of
shares subject to the stock options on the one-year anniversary of
the vesting commencement date with the remainder vesting in 36
successive equal monthly installments, subject to the employee’s
continued service with the Company on each such date.
About Incyte A global biopharmaceutical company on a
mission to Solve On., Incyte follows the science to find solutions
for patients with unmet medical needs. Through the discovery,
development and commercialization of proprietary therapeutics,
Incyte has established a portfolio of first-in-class medicines for
patients and a strong pipeline of products in Oncology and
Inflammation & Autoimmunity. Headquartered in Wilmington,
Delaware, Incyte has operations in North America, Europe and
Asia.
For additional information on Incyte, please visit Incyte.com or
follow us on social media: LinkedIn, X, Instagram, Facebook,
YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240329198758/en/
Media media@incyte.com
Investors ir@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Aug 2023 to Aug 2024